Diabetes and Medicare competitive bidding: the "perfect storm" for patient harm

Area of Science:

• Health policy
• Diabetes management
• Medical economics

Background:

• Medicare's competitive bidding program (CBP) impacts durable medical equipment pricing.
• Diabetes test strips are essential for blood glucose monitoring.
• Previous assessments of the CBP's effectiveness in the diabetes supply market are limited.

Purpose of the Study:

• To evaluate the impact of Medicare's CBP on the availability and quality of diabetes test strips.
• To analyze the findings of a recent Diabetes Care study regarding the CBP.
• To provide recommendations for the Centers for Medicare & Medicaid Services (CMS) concerning the CBP for diabetes test strips.

Main Methods:

• Analysis of a recent Diabetes Care study's findings.
• Discussion of the implications of the study's co-authors.
• Review of the competitive bidding process for diabetes test strips under Medicare.

Main Results:

• The Diabetes Care study identified significant flaws within Medicare's competitive bidding program for diabetes test strips.
• These flaws raise concerns about the program's impact on beneficiaries and the healthcare system.
• The study's co-authors advocate for a suspension of the current bidding program.

Conclusions:

• The current Medicare competitive bidding program for diabetes test strips is flawed and requires reevaluation.
• CMS should consider suspending the program to address identified issues.
• Policy adjustments are needed to ensure adequate access to essential diabetes testing supplies.